Ellence (epirubicin) could be a cancer medication that interferes with the expansion and unfold of cancer cells within the body.

Ellence is employed to treat carcinoma.

Ellence may additionally be used for functions unlisted during this medication guide.

Submit your review

Create your own review

Average rating:  
 0 reviews
  • Ellence
  • Get emergency medical help if you have any signs of an allergic reaction to Ellence: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

    Tell your caregivers at once if you have:

    feeling short of breath, even with mild exertion;
    swelling, rapid weight gain (especially in your face and midsection);
    irritation or skin changes where the injection was given;
    nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
    fast, slow, or uneven heartbeats;
    anxiety, sweating, severe shortness of breath, wheezing, gasping for breath;
    chest pain, sudden cough, cough with foamy mucus, rapid breathing, coughing up blood;
    lower back pain, blood in your urine, little or no urinating;
    numbness or tingly feeling around your mouth, weak pulse, overactive reflexes, confusion, fainting;
    muscle weakness, tightness, or contraction;
    fever, chills, body aches, flu symptoms, sores in your mouth and throat; or
    pale skin, easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin.
    Common Ellence side effects may include:

    hot flashes, missed menstrual periods;
    temporary hair loss;
    feeling weak or tired;
    mild nausea, diarrhea; or
    eye redness, puffy eyelids.
  • When possible, to reduce the risk of developing cardiotoxicity in patients receiving ELLENCE after stopping treatment with other cardiotoxic agents, especially those with long half-lives such as trastuzumab, ELLENCE-based therapy should be delayed until the other agents have cleared from the circulation. Administer ELLENCE Injection by intravenous infusion. Give ELLENCE in repeated 3- to 4-week cycles. The total dose of ELLENCE may be given on Day 1 of each cycle or divided equally and given on Days 1 and 8 of each cycle. The recommended dosages of ELLENCE are as follows: